OMS643762
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OMS643762, covering 2018-10-22 to 2018-10-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects [Phase 2]